VIDEO: Innovations in treatment technologies will benefit optometrists’ patients

ByJustin A. Schweitzer, OD, FAAO

ByNancy Hemphill, ELS, FAAO

Fact checked byNancy Hemphill, ELS, FAAO

LAS VEGAS – A variety of glaucoma and cataract technologies in the pipeline now will help optometric patients in the future, Justin A. Schweitzer, OD, FAAO, of Vance Thompson Vision Center in Sioux Falls, S.D., said at Vision Expo West.

A number of glaucoma drug delivery devices are being investigated, he said, with bimatoprost SR (Allergan) currently on the market. Intracanalicular inserts are in the pipeline along with a travoprost implant (Ocular Therapeutix) and drug-eluting contact lenses that may help reduce the medication burden for patients.

Multiple accommodative IOLs are also being developed, using fluid or silicone to change the radius of curvature of the lens to provide accommodative amplitude.

Published by:

Sources/Disclosures

Collapse

Source:

Schweitzer J, et al. Today’s research for tomorrow’s treatment: What is in the pipeline. Presented at: Vision Expo West; Sept. 14-17, 2022; Las Vegas.

Disclosures: Schweitzer reports being a consultant for Allergan and Glaukos.

Vision Expo West

Read more

VIDEO: Innovations in treatment technologies will benefit optometrists’ patients

Related Content